I get what your poster is saying on ARIVA TG, but I think it is wrong.
It will be a case of continued improvement in production, a reduction in ASIC, BUT IMPORTANTLY, a renegotiation of the debt funding so it is a sustainable operation. This is where the crux of it is. It wouldn't surprise me if they came out with a statement prior to christmas that there are improved repayment schedules based on realistic production figures and update LOM.
- Forums
- ASX - By Stock
- TGS
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-7
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TGS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online